Revolution Medicines, Inc. (RVMD) earnings
RVMD earnings moved a median of +1.48% by the close. Quarterly and annual RVMD reports and results, each read against the price at its own news timestamp. Back to the RVMD overview →
30 measured RVMD earnings events.
Where these RVMD earnings landedvs 30 measured RVMD earnings reactions
| Middle 50% of RVMD earnings reactions | -1.59% to +2.76% |
|---|---|
| Median reaction (to close) | +1.48% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 RVMD earnings events with a measured close landed between -1.59% and +2.76%; 63% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Revolution Medicines, For: Jun 30 | SEC filing · Form 10-Q | -0.19% | -0.13% | |
| Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress | Press release | -0.19% | -0.13% | |
| Revolution Medicines to Report Financial Results for Second Quarter 2026 After Market Close on August 5, 2026 | Press release | +0.68% | +4.60% | |
| Form 10-Q Revolution Medicines, For: Mar 31 | SEC filing · Form 10-Q | -0.66% | -4.23% | |
| Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress | Press release | -0.66% | -4.23% | |
| Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026 | Press release | -1.61% | +0.26% | |
| Form 10-K Revolution Medicines, For: Dec 31 | SEC filing · Form 10-K | +3.92% | +7.00% | |
| Form 10-Q Revolution Medicines, For: Sep 30 | SEC filing · Form 10-Q | +3.51% | +2.76% | |
| Revolution Medicines Reports Third Quarter 2025 Financial Results and Update on Corporate Progress | Press release | +3.51% | +2.76% | |
| Revolution Medicines to Report Financial Results for Third Quarter 2025 After Market Close on November 5, 2025 | Press release | +1.14% | +1.80% | |
| Form 10-Q Revolution Medicines, For: Jun 30 | SEC filing · Form 10-Q | +3.69% | +2.25% | |
| Revolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate Progress | Press release | +3.69% | +2.25% | |
| Revolution Medicines to Report Financial Results for Second Quarter 2025 After Market Close on August 6, 2025 | Press release | +1.26% | +1.17% | |
| Form 10-Q Revolution Medicines, For: Mar 31 | SEC filing · Form 10-Q | +0.54% | +2.80% | |
| Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress | Press release | +0.54% | +2.80% | |
| Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025 | Press release | -2.02% | +0.59% | |
| Form 10-K Revolution Medicines, For: Dec 31 | SEC filing · Form 10-K | +0.56% | -2.06% | |
| Form 10-Q Revolution Medicines, For: Sep 30 | SEC filing · Form 10-Q | +1.69% | +1.90% | |
| Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress | Press release | +1.69% | +1.90% | |
| Revolution Medicines to Report Financial Results for Third Quarter 2024 After Market Close on November 6, 2024 | Press release | +0.92% | +6.62% | |
| Form 10-Q Revolution Medicines, For: Jun 30 | SEC filing · Form 10-Q | +5.04% | +4.69% | |
| Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress | Press release | +5.04% | +4.69% | |
| Revolution Medicines to Report Financial Results for Second Quarter 2024 After Market Close on August 7, 2024 | Press release | +1.50% | -0.18% | |
| Form 10-Q Revolution Medicines, For: Mar 31 | SEC filing · Form 10-Q | -1.38% | -4.59% | |
| Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress | Press release | -1.38% | -4.59% | |
| Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024 | Press release | -0.64% | +0.41% | |
| Form 10-K Revolution Medicines, For: Dec 31 | SEC filing · Form 10-K | -4.05% | -3.22% | |
| Form 10-Q Revolution Medicines, For: Sep 30 | SEC filing · Form 10-Q | -2.79% | -4.74% | |
| Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress | Press release | -2.79% | -4.74% | |
| Revolution Medicines to Report Financial Results for Third Quarter 2023 After Market Close on November 6, 2023 | Press release | -0.81% | +2.73% |
Keep exploring
More RVMD: analyst actions → · SEC filings → · RVMD overview →